Qiming Venture Partners — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Dualitas Therapeutics develops bispecific antibody therapies that pair a proprietary proximity engager arm with an antibody against a therapeutic target, using its DualScreen discovery engine to identify synergistic target combinations.
BiotechDeep TechSouth San Francisco, US
Forbes Huang(Co-Founder, Chief Operating Officer & Chief Business Officer)Greg Lazar(Co-Founder & Chief Scientific Officer)Richard Murray(Executive Officer, Director)Karim Dabbagh(Chief Executive Officer, Board Member)
BoardAlicia Levey(Director)Michael Ross(Director)
Co-investorsSV Health InvestorsVersant VenturesDementia Discovery FundQiming Healthcare
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.